Chantilly Bio Pharma Private Limited

Chantilly Bio Pharma Private Limited - research & development in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74999TG2011PTC075331 Incorporated 04 July 2011 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company research and development
Revenue · FY 2025
₹49.02 Lakh
▲ 20% YoY
Net profit · FY 2025
₹98,394
Net margin 2%
EBITDA · FY 2025
₹3.66 Lakh
EBITDA margin 7.5%
Authorised capital
₹12 Lakh
Registered with MCA
Paid-up capital
₹11.66 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered

About Chantilly Bio Pharma Private Limited

Data last updated:

Chantilly Bio Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Venkor Cpeciality Products Llc. It operates in the research and development sector. It was incorporated on 04 July 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2011PTC075331. Its GSTIN is 36AAECC4510C2Z9 (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹11.66 Lakh. It is led by directors including Cherukuri Subraman Rao (Managing Director) and Nagajyothi Balusu.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.11 – 150/15 & 16 2nd Floor Sri Sai Sadan Patwari Enclave Gandhinagar Balanagar, Hyderabad, Telangana, India – 500037.

As per the financials filed for FY 2025, the company reported a revenue of ₹49.02 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹98,394 (net margin 2%) and EBITDA of ₹3.66 Lakh (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 9% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999TG2011PTC075331
Registration Number 075331
Incorporation Date 04 July 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Venkor Cpeciality Products Llc
Compliance Status Active Compliant

CIN history

Chantilly Bio Pharma has one previous CIN (Corporate Identification Number): U74999AP2011PTC075331. The current CIN is U74999TG2011PTC075331, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74999TG2011PTC075331Current
U74999AP2011PTC075331Previous

Contact details

Chantilly Bio Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H.No.11 – 150/15 & 16 2nd Floor Sri Sai Sadan Patwari Enclave Gandhinagar Balanagar, Hyderabad, Telangana, India – 500037
  • Industry
    Research & Development, Research & Development

To see the full contact details of Chantilly Bio Pharma Private Limited, buy the company report.

Comprehensive company report
Chantilly Bio Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Chantilly Bio Pharma is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Chantilly Bio Pharma Private Limited, buy the company report.

Financials of Chantilly Bio Pharma Private Limited

FY 2025 filings available

Chantilly Bio Pharma Private Limited reported revenue of ₹49.02 Lakh (up 20% YoY) for FY 2025.

Revenue · FY 2025
₹49.02 Lakh ▲ 20%
Net profit · FY 2025
₹98,394 margin 2%
EBITDA · FY 2025
₹3.66 Lakh margin 7.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 12%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 24%
5 years · compounded
▲ 20%

Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 20% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.66 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹98,394
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.5%
Net Profit Margin2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Chantilly Bio Pharma Private Limited, buy the company report.

Board of directors of Chantilly Bio Pharma Private Limited

Chantilly Bio Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nagajyothi BalusuDirector08 Jun 20197 Years 5 MonthsCurrent
Kanaka Malneedi DurgaDirector04 Jul 201115 Years 4 MonthsCurrent
Cherukuri Subraman RaoManaging Director06 Apr 201511 Years 7 MonthsCurrent

Peer comparison

Chantilly Bio Pharma Private Limited is compared with the 6 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Flowian Solutions Private Limited₹49.41 Lakh (FY 2020)-38.0%Pune, Maharashtra, India
World Researchers Associations₹49.17 Lakh (FY 2024)-3.0%Indore, Madhya Pradesh, India
Emprocell Clinical Research Private Limited₹49.13 Lakh (FY 2020)-51.0%Navi Mumbai, Maharashtra, India
Chantilly Bio Pharma Private Limitedthis company₹49.02 Lakh (FY 2025)₹98,3942%20.0%Hyderabad, Telangana, India
Unicas Biotech Private Limited₹48.99 Lakh (FY 2025)102.0%Hyderabad, Telangana, India
Shilbey Design and Consultancy Private Limited₹48.69 Lakh (FY 2023)255.0%Kadi, Gujarat, India
Neuranceai Technologies Private Limited₹48.34 Lakh (FY 2024)-41.0%Bengaluru, Karnataka, India

To see the full peer comparison of Chantilly Bio Pharma Private Limited, buy the company report.

Auditor

Chantilly Bio Pharma Private Limited is audited by A UDAY BHASKAR & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
A UDAY BHASKAR & COFY 2017016984S

Shareholding

The shareholding of Chantilly Bio Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Chantilly Bio Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Chantilly Bio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Chantilly Bio Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAECC4510C2Z9TelanganaActive18 Feb 2020

To see the full GST registrations and return filing status of Chantilly Bio Pharma Private Limited, buy the company report.

Recent activity

Chantilly Bio Pharma Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Nagajyothi Balusu was appointed as Director on 08 Jun 2019.

AGM
Chantilly Bio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Chantilly Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Nagajyothi Balusu was appointed as Director.
Ceased
Venkata Nageswara Rao Cherukuri ceased to be Director.
Appointed
Cherukuri Subraman Rao was appointed as Managing Director.
Ceased
Kanaka Malneedi Durga ceased to be Managing Director.
Appointed
Kanaka Malneedi Durga was appointed as Director.
Incorporation
04 Jul 2011
Chantilly Bio Pharma Private Limited was registered on 04 Jul 2011 with Roc Hyderabad & aged 15 years 4 months as per MCA records.

Frequently asked questions

Chantilly Bio Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in the research and development industry. It was incorporated on 04 July 2011 (15+ years old) and is registered under CIN U74999TG2011PTC075331.

Chantilly Bio Pharma has 3 current directors:

The latest financial statements of Chantilly Bio Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Chantilly Bio Pharma is 36AAECC4510C2Z9, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Chantilly Bio Pharma is U74999TG2011PTC075331. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Chantilly Bio Pharma was incorporated on 04 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Chantilly Bio Pharma by revenue are Flowian Solutions Private Limited, World Researchers Associations, Emprocell Clinical Research Private Limited, Unicas Biotech Private Limited, Shilbey Design and Consultancy Private Limited and 1 more, all in the same principal business activity (scientific research and development).

Nagajyothi Balusu was appointed as Director on 08 Jun 2019. Venkata Nageswara Rao Cherukuri ceased to be Director on 23 Jan 2016. Cherukuri Subraman Rao was appointed as Managing Director on 06 Apr 2015. Chantilly Bio Pharma has 5 board changes on record in total.

The registered office of Chantilly Bio Pharma is at H.No.11 – 15015 & 16 2nd Floor Sri Sai Sadan Patwari Enclave Gandhinagar Balanagar, Hyderabad, Telangana, India – 500037.

Chantilly Bio Pharma operates in the research and development industry.

The compliance status of Chantilly Bio Pharma is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.